Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


ERYTHROPOIESIS ABNORMAL side effect

What is ERYTHROPOIESIS ABNORMAL ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   ERYTHROPOIESIS ABNORMAL and Recently Reported Side Effects   ERYTHROPOIESIS ABNORMAL and 15 most Active Side Effect polls   ERYTHROPOIESIS ABNORMAL and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with ERYTHROPOIESIS ABNORMAL

ARANESP  AUGMENTIN  EXJADE  IMATINIB  ROSIGLITAZONE  TOSITUMOMAB  TRIMETHOPRIM  VINCRISTINE  


Tositumomab Side Effects Report #5407108-2
Consumer or non-health professional from UNITED STATES reported TOSITUMOMAB problem on July 24, 2007. Male patient, 50 years of age, was treated with TOSITUMOMAB. After drug was administered, patient experienced the following problems/side effects: erythropoiesis abnormal, myelodysplastic syndrome, thrombocytopenia, . TOSITUMOMAB dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADRIAMYCIN PFS, VINCRISTINE, PREDNISONE, RITUXAN, IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient recovered.

Exjade Side Effects Report #5780261-7
EXJADE problem was reported by a Consumer or non-health professional from UNITED STATES on June 12, 2008. Male patient, weighting 167.6 lb, was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: erythropoiesis abnormal, transfusion, . EXJADE dosage: 1000 MG, QD. Patient recovered.

Trimethoprim Side Effects Report #5458142-8
Consumer or non-health professional from UNITED KINGDOM reported TRIMETHOPRIM problem on Sept 03, 2007. Female patient was treated with TRIMETHOPRIM. After drug was administered, patient experienced the following problems/side effects: anaemia, erythropoiesis abnormal, vasculitic rash, . TRIMETHOPRIM dosage: 100 MG (100 MG, 1 IN 1 D) ORAL. Patient recovered.

Aranesp Side Effects Report #5378842-8
ARANESP problem was reported by a Health Professional from UNITED STATES on June 26, 2007. Male patient, weighting 218.5 lb, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: erythropoiesis abnormal, hospitalisation, therapeutic response decreased, . ARANESP dosage: unknown. During the same period patient was treated with LASIX, DARVOCET, DOXAZOSIN MESYLATE, POTASSIUM ACETATE. Patient was hospitalized. Patient recovered.


Aranesp Side Effects Report #5378842-8
Health Professional from UNITED STATES reported ARANESP problem on June 26, 2007. Male patient, weighting 218.5 lb, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: erythropoiesis abnormal, hospitalisation, therapeutic response decreased, . ARANESP dosage: unknown. During the same period patient was treated with LASIX, DARVOCET, DOXAZOSIN MESYLATE, POTASSIUM ACETATE. Patient was hospitalized. Patient recovered.

Vincristine Side Effects Report #5712902-4
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, erythropoiesis abnormal, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Imatinib Side Effects Report #5430651-7
Consumer or non-health professional from SPAIN reported IMATINIB MESYLATE problem on Aug 08, 2007. Male patient, 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: anaemia, chromosome analysis abnormal, erythropoiesis abnormal, myelodysplastic syndrome, neutropenia, . IMATINIB MESYLATE dosage: 400 MG/DAY. During the same period patient was treated with IMATINIB MESYLATE, INTERFERON ALFA. Patient recovered.

Rosiglitazone Side Effects Report #5736907-2
ROSIGLITAZONE MALEATE problem was reported by a Consumer or non-health professional from ITALY on Apr 28, 2008. Male patient, 47 years of age, was diagnosed with secondary immunodeficiency and was treated with ROSIGLITAZONE MALEATE. After drug was administered, patient experienced the following problems/side effects: anaemia, erythropoiesis abnormal, . ROSIGLITAZONE MALEATE dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, CYCLOSPORINE, NIFEDIPINE, FUROSEMIDE, BICARBONATE, ALLOPURINOL, RAMIPRIL, CALCITRIOL. Patient recovered.

Augmentin Side Effects Report #5704430-7
Consumer or non-health professional from FRANCE reported AUGMENTIN problem on Apr 04, 2008. Male patient, 78 years of age, was diagnosed with febrile infection and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: anaemia, bone marrow myelogram abnormal, erythropoiesis abnormal, haemoglobin decreased, neutrophil count decreased, pancytopenia, platelet count decreased, red blood cell count decreased, thrombocytopenia, . AUGMENTIN dosage: unknown. During the same period patient was treated with XATRAL, PROSCAR, TOPALGIC, CALCIPARINE, COZAAR, PLAVIX, OMEPRAZOLE, ALPRAZOLAM. Patient was hospitalized. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about ERYTHROPOIESIS ABNORMAL side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about ERYTHROPOIESIS ABNORMAL